1.8403
19.13%
0.2703
Mira Pharmaceuticals Inc stock is traded at $1.8403, with a volume of 4.01M.
It is up +19.13% in the last 24 hours and up +61.23% over the past month.
Mira Pharmaceuticals Inc is a pre-clinical-stage pharmaceutical development company with two neuroscience programs targeting a broad range of neurologic and neuropsychiatric disorders. The company's novel oral pharmaceutical marijuana, MIRA-55, is under investigation for treating adult patients suffering from anxiety and cognitive decline, often associated with early-stage dementia.
See More
Previous Close:
$1.57
Open:
$1.64
24h Volume:
4.01M
Relative Volume:
2.21
Market Cap:
$25.54M
Revenue:
-
Net Income/Loss:
$-12.78M
P/E Ratio:
-
EPS:
-
Net Cash Flow:
$-4.71M
1W Performance:
+78.12%
1M Performance:
+61.23%
6M Performance:
+120.04%
1Y Performance:
-18.33%
Mira Pharmaceuticals Inc Stock (MIRA) Company Profile
Name
Mira Pharmaceuticals Inc
Sector
Industry
Phone
813-369-5150
Address
1200 BRICKELL AVENUE, MIAMI
Mira Pharmaceuticals Inc Stock (MIRA) Latest News
MIRA Pharmaceuticals Shares Surge 40% After Ketamir-2 Excels in Pain Management Trials - Yahoo Finance UK
Tiny Healthcare Stock With $35 Million Market Cap Becomes Major Player Overnight In Rapidly Growing $1 Billion Market - Barchart
Becton, Dickinson And Company Earnings Preview: What To Expect - Barchart
1 'Strong Buy' Dividend Stock That Insiders Are Buying - Barchart
Transcat (NASDAQ:TRNS) Reports Sales Below Analyst Estimates In Q3 Earnings - Barchart
Tapestry, Capri File Notice To Appeal Court Decision Blocking Their $8.5 Billion Merger - Barchart
AI Platform Haiper Launches Powerful 2.0 Video Model For Increased Realism And Faster Generations - Barchart
MIRA Pharmaceuticals' Formulated Shows Greater Efficacy Than FDA-Approved Drug For Chemo-Induced Neuropathic Pain - Yahoo Finance
Canadian-led high seas mission finds illegal harvesting of shark fins and "dark vessels" in North Pacific - Barchart
Why Is MicroStrategy (MSTR) Stock Rocketing Higher Today - Barchart
3 Stocks That Goldman Sachs Expects To Beat The Market In 2025 - Barchart
Hope for Chemo Patients: New Pre-Clinical Study Shows Mira Pharmaceuticals Ketamir-2 Beats Competitors' Chemo Pain Reduction by Over 60% - Barchart
Report: Washington Post loses more than 200,000 subscriptions following non-endorsement - Barchart
Ketamir-2 shows promise in preclinical pain study - Investing.com India
Soleno Therapeutics To Participate In Upcoming November Investor Conferences - Barchart
MIRA Pharmaceuticals' Ketamir-2 Shows 60% Greater Efficacy Than FDA-Approved Gabapentin in Reversing Chemotherapy-Induced Neuropathic Pain - Brazosport Facts
Ranger Energy: Q3 Earnings Snapshot - Barchart
Uranium Royalty Acquires Existing Royalty on Cameco's Advanced Stage Millennium and Cree Extension Uranium Projects - Barchart
Weekly Roundup on the Cannabis Sector & Psychedelic Sector 10-28-2024 - Market Exclusive
Real Estate Sector Outperforms: 3 Stocks To Gain Exposure - Barchart
Mira Pharmaceuticals reports preclinical success with Ketamir-2 By Investing.com - Investing.com Australia
Ketamir-2 from MIRA Pharmaceuticals Raises the Bar in Pain Management, Outshining FDA-Approved Treatments - Barchart
Mira Pharmaceuticals reports preclinical success with Ketamir-2 - Investing.com India
Mega-Cap Tech Stocks To Buy For AI Growth: AMZN And META - Barchart
Toronto Stock Exchange, Volatus Aerospace Inc., The View From The C-Suite - Barchart
Triple Negative Breast Cancer Pipeline 2024: Clinical Trials Assessment, FDA Approvals, Therapies, and Key Companies Involved by DelveInsight | ModernaTX, Inc., OncoTherapy Science, Phoenix Molecular - Barchart
EHP FUNDS INC. ANNOUNCES RESULTS OF UNITHOLDER MEETING FOR EHP SELECT ALTERNATIVE FUND - Barchart
Sustainable Pharmaceutical Packaging Market Top Business Strategy, Industry Growth Factors, Latest Trends and Future Opportunities Analysis - Barchart
Olin: Q3 Earnings Snapshot - Barchart
Verizon Stock Slips After Mixed Earnings Leave Wall Street And Retail Unimpressed - Barchart
QuantumScape Stock Bounces Back After Earnings Call Boost, Tesla Tailwinds: Retail Turns Optimistic - Barchart
CTLT Stock Falls As Potential Hindrance To NVO Buyout Deal Increases - Barchart
Stocks Rise On Strong Earnings Results And Soft-Landing Optimism - Barchart
Metastatic Colorectal Cancer Pipeline 2024: Clinical Trials Assessment, FDA Approvals, Therapies, and Key Companies Involved by DelveInsight | Daiichi Sankyo Company, Mirati Therapeutics, Apollomics - Barchart
Stocks In Play: Kits Eyecare Ltd. - Barchart
CPKC Reports Third-Quarter Results Driven By Solid Execution; Poised For Strong Finish To 2024 - Barchart
Why Apple (AAPL) Shares Are Sliding Today - Barchart
QuantumScape Slips 3% Ahead Of Earnings: Retail Stays On The Sidelines - Barchart
Is Amazon Stock A Buy Ahead Of Q3 Earnings? - Barchart
3 Restaurant Stocks Likely To Surpass Q3 Earnings Expectations - Barchart
Vabysmo, Hemlibra Drive Roches Sales In Q3 & First 9 Months Of 2024 - Barchart
NextEra Energy Stock Charges Up After Better-Than-Expected Q3 Profit: Retail Feels Exuberant - Barchart
New Strong Buy Stocks For October 23rd - Barchart
Rambus Stock Poised For Growth – Will The AI Boom Deliver? - Barchart
The Daily Hit: October 22, 2024 - Green Market Report
ROBERT HALF REPORTS THIRD-QUARTER FINANCIAL RESULTS - Barchart
Sangamo Therapeutics, Cyclacel Pharma, GE Aerospace: 3 Stocks Retailers Are Most Bullish Tuesday Afternoon - Barchart
MIRA says ketamine-based drug beats current pain treatments in study - Green Market Report
AGNC Stock Dips After Q3 Earnings Miss: Retail Stays Positive - Barchart
Chipotle Aims To Slash Hiring Time By 75% With AI Platform; Retail Turns Bearish Ahead of Earnings - Barchart
Freeport-McMoRan Stock Rises After Upbeat Q3 Earnings: Retail Cheers The Report - Barchart
Mira Pharmaceuticals Inc Stock (MIRA) Financials Data
Revenue
Net Income
Cash Flow
EPS
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):